Fraport Traffic Figures – October 2020: Passenger Traffic Remains Low at Frankfurt Airport

FRA’s cargo throughput achieves strong performance – Fraport Group airports worldwide report mixed results

PR Newswire

FRANKFURT, Germany, Nov. 12, 2020 /PRNewswire/ — FRA/rap – In October 2020, Frankfurt Airport (FRA) served some 1.1 million passengers – an 83.4 percent decline compared to the same month last year.  FRA’s cumulative traffic during the January-to-October 2020 period fell by 71.6 percent, because of low passenger demand resulting from the persisting travel restrictions amid the Covid-19 pandemic. In contrast, Frankfurt Airport recorded very positive cargo performance, exceeding year-on-year levels for the first time since 15 months. In October 2020, FRA’s cargo throughput (comprising airfreight and airmail) grew by 1.6 percent to 182,061 metric tons – with cargo-only flights more than compensating for the ongoing capacity constraints for “belly freight” (transported on passenger aircraft). This high cargo demand can be attributed mainly to the upturn in global trade and the solid performance of the Eurozone’s industrial sector.

Aircraft movements at FRA decreased by 62.8 percent year-on-year to 17,105 takeoffs and landings in the reporting month. Accumulated maximum takeoff weights (MTOWs) contracted by 59.5 percent to about 1.1 million metric tons.

Across the Group, Fraport’s international airport portfolio continued to register widely varying traffic performance in October 2020. Some Group airports – particularly in Greece, Brazil and Peru – reported noticeably smaller declines in passenger traffic on a percentage basis compared to the preceding month.

Traffic at Slovenia’sLjubljana airport (LJU) fell by 89.1 percent year-on-year to 10,775 passengers. The Brazilian airports of Fortaleza (FOR) and Porto Alegre (POA) saw combined traffic sink by 57.5 percent to 569,453 passengers. Peru’s capital city airport in Lima (LIM) reported an 82.8 percent drop in traffic to 345,315 passengers, due to of the ongoing strong travel restrictions in international traffic.

At the 14 Greek regional airports, traffic decreased by 55.3 percent to some 1.1 million passengers.  On the Bulgarian Black Sea coast, the Twin Star airports of Burgas (BOJ) and Varna (VAR) together welcomed 56,415 passengers in October 2020, down 61.3 percent year-on-year.

Antalya Airport (AYT) on the Turkish Riviera posted a 55.3 percent drop in traffic to approximately 1.9 million passengers in the reporting month.  Russia’s Pulkovo Airport in St. Petersburg recorded a 33.3 percent fall in traffic to around 1.1 million passengers. In China, Xi’an Airport (XIY) received about 3.6 million passengers – representing a 12.7 percent dip in traffic compared to the same month last year.  

Print-quality photos of Fraport AG and Frankfurt Airport are available for free downloading via the photo library on the Fraport Web site. For TV news and information broadcasting purposes only, we also offer free footage material for downloading.  If you wish to meet a member of our Media Relations team when at Frankfurt Airport, please do not hesitate to contact us. Our contact details are available here.

Fraport AG

Torben Beckmann 

Telephone: +49 69 690-70553

Corporate Communications  

E-mail: [email protected]

60547 Frankfurt, Germany 


www.fraport.com

For further information about Fraport AG please click here.


January


February


Jan-Feb


March


Jan-March


Q 1


April


Jan-Apr


May


Jan-May


June


Jan-Jun


Q 2


1stHY


Passengers


2020

4,620,966

4,372,562

8,993,528

2,124,005

11,117,533

11,117,533

188,078

11,305,611

272,826

11,578,437

599,314

12,177,751

1,060,218

12,177,751


2019

4,652,187

4,554,345

9,206,532

5,592,516

14,799,048

14,799,048

6,039,842

20,838,890

6,225,994

27,064,884

6,580,587

33,645,471

18,846,423

33,645,471


Change %

-0.7

-4.0

-2.3

-62.0

-24.9

-24.9

-96.9

-45.7

-95.6

-57.2

-90.9

-63.8

-94.4

-63.8


Cargo (ld. + unld. + transit) (t)


2020

149,217

148,500

297,717

167,279

464,996

464,996

141,337

606,333

160,502

766,835

145,562

912,396

447,400

912,396


2019

163,332

161,366

324,698

202,452

527,151

527,151

178,342

705,493

185,701

891,194

174,392

1,065,586

538,435

1,065,586


Change %

-8.6

-8.0

-8.3

-17.4

-11.8

-11.8

-20.7

-14.1

-13.6

-14.0

-16.5

-14.4

-16.9

-14.4


Cargo (ld. + unld.) (t)


2020

146,645

146,105

292,751

164,806

457,557

457,557

138,065

595,621

157,380

753,001

141,911

894,912

437,355

894,912


2019

161,466

158,862

320,328

198,700

519,028

519,028

174,895

693,923

182,235

876,158

171,444

1,047,602

528,574

1,047,602


Change %

-9.2

-8.0

-8.6

-17.1

-11.8

-11.8

-21.1

-14.2

-13.6

-14.1

-17.2

-14.6

-17.3

-14.6


   – Air Freight (t)


2020

142,066

142,882

284,948

162,557

447,505

447,505

138,406

585,911

156,324

742,235

141,144

883,379

435,874

883,379


       (ld. + unld. + transit) (t)


2019

156,159

154,587

310,746

194,646

505,392

505,392

171,050

676,442

178,272

854,714

168,096

1,022,810

517,418

1,022,810


Change %

-9.0

-7.6

-8.3

-16.5

-11.5

-11.5

-19.1

-13.4

-12.3

-13.2

-16.0

-13.6

-15.8

-13.6


   – Mail (t)


2020

7,151

5,618

12,769

4,722

17,491

17,491

2,931

20,422

4,178

24,600

4,418

29,017

11,526

29,017


       (ld. + unld. + transit) (t)


2019

7,173

6,779

13,952

7,807

21,759

21,759

7,292

29,050

7,429

36,480

6,296

42,776

21,017

42,776


Change %

-0.3

-17.1

-8.5

-39.5

-19.6

-19.6

-59.8

-29.7

-43.8

-32.6

-29.8

-32.2

-45.2

-32.2


ATMs (1)


2020

36,391

35,857

72,248

22,838

95,086

95,086

6,512

101,598

7,764

109,362

9,331

118,693

23,607

118,693


2019

37,676

36,849

74,525

42,056

116,581

116,581

43,683

160,264

46,181

206,445

45,871

252,316

135,735

252,316


Change %

-3.4

-2.7

-3.1

-45.7

-18.4

-18.4

-85.1

-36.6

-83.2

-47.0

-79.7

-53.0

-82.6

-53.0


MTOW (arr.) in metric tonnes (1)


2020

2,323,141

2,221,905

4,545,046

1,611,719

6,156,764

6,156,764

664,022

6,820,786

776,676

7,597,462

758,935

8,356,397

2,199,633

8,356,397


2019

2,372,825

2,281,460

4,654,285

2,649,601

7,303,886

7,303,886

2,668,593

9,972,479

2,816,707

12,789,187

2,810,214

15,599,400

8,295,514

15,599,400


Change %

-2.1

-2.6

-2.3

-39.2

-15.7

-15.7

-75.1

-31.6

-72.4

-40.6

-73.0

-46.4

-73.5

-46.4


Traffic Units (arr. + dep. + transit)


2020

6,113,133

5,857,563

11,970,696

3,796,799

15,767,495

15,767,495

1,601,445

17,368,941

1,877,843

19,246,784

2,054,929

21,301,713

5,534,218

21,301,713


2019

6,285,509

6,168,005

12,453,514

7,617,040

20,070,553

20,070,553

7,823,263

27,893,816

8,083,007

35,976,823

8,324,506

44,301,329

24,230,775

44,301,329


Change %

-2.7

-5.0

-3.9

-50.2

-21.4

-21.4

-79.5

-37.7

-76.8

-46.5

-75.3

-51.9

-77.2

-51.9


Traffic Units (arr.+dep.)


2020

6,078,818

5,828,629

11,907,447

3,770,323

15,677,770

15,677,770

1,568,164

17,245,934

1,845,986

19,091,921

2,018,097

21,110,018

5,432,248

21,110,018


2019

6,258,447

6,135,562

12,394,009

7,566,878

19,960,887

19,960,887

7,781,658

27,742,545

8,039,704

35,782,249

8,283,723

44,065,972

24,105,085

44,065,972


Change %

-2.9

-5.0

-3.9

-50.2

-21.5

-21.5

-79.8

-37.8

-77.0

-46.6

-75.6

-52.1

-77.5

-52.1


PAX/PAX-ATM (2)


2020

135.7

130.6

133.2

106.8

127.2

127.2

60.5

124.9

79.9

123.2

101.4

122.0

85.3

122.0


2019

132.5

132.6

132.5

143.1

136.3

136.3

147.3

139.4

144.1

140.4

152.9

142.7

148.1

142.7


Change %

2.5

-1.6

0.5

-25.4

-6.7

-6.7

-58.9

-10.4

-44.6

-12.2

-33.7

-14.5

-42.4

-14.5


Seat Load Factor


2020

73.3%

70.5%

71.9%

54.2%

67.7%

67.7%

20.1%

65.1%

24.4%

62.6%

56.8%

62.3%

34.1%

62.3%


2019

72.4%

72.9%

72.6%

78.0%

74.6%

74.6%

80.8%

76.3%

78.9%

76.9%

82.7%

77.9%

80.8%

77.9%


Change %P

0.9

-2.4

-0.7

-23.8

-6.9

-6.9

-60.7

-11.2

-54.5

-14.2

-25.9

-15.6

-46.7

-15.6


Punctionality


2020

82.7%

80.4%

81.6%

86.1%

82.6%

82.6%

79.2%

82.4%

79.3%

82.2%

82.4%

82.2%

80.5%

82.2%


2019

75.6%

83.1%

79.3%

71.5%

76.5%

76.5%

74.9%

76.1%

68.0%

74.3%

64.4%

72.5%

69.0%

72.5%


Change %P

7.0

-2.7

2.2

14.6

6.1

6.1

4.3

6.3

11.3

7.9

17.9

9.7

11.5

9.7

Notes:  (1) only civil traffic    (2) scheduled and charter traffic  

 

Cision View original content:http://www.prnewswire.com/news-releases/fraport-traffic-figures–october-2020-passenger-traffic-remains-low-at-frankfurt-airport-301171328.html

SOURCE Fraport AG

Iwatani Corporation of America and Toyota Collaborate to Bring Seven New Hydrogen Refueling Stations to Southern California

Expansion Supports the U.S. Launch of Toyota’s Second Generation Mirai, its Zero-Emission Hydrogen Fuel Cell Electric Vehicle

PR Newswire

SANTA CLARA, Calif., Nov. 12, 2020 /PRNewswire/ — Iwatani Corporation of America, a wholly owned subsidiary of Iwatani Corporation (Tokyo Stock Exchange: 8088) and Toyota Motor North America (NYSE: TM) jointly announced today that Toyota will support Iwatani’s plans to significantly expand the number of open retail hydrogen fueling stations by nearly 25 percent in Southern California and represents an increase of 6,300 kilograms per day of hydrogen fuel dispensing capacity. Construction of the new stations is anticipated to commence in early 2021 followed by commissioning of the first stations by midyear. All seven stations will be open to the public, providing hydrogen fuel to consumers in support of the rapidly growing demand for zero-emission fuel cell electric vehicles (FCEVs).

The seven new retail stations will deploy the latest H2Station™ hydrogen fuel dispensing technology provided by Nel Hydrogen. Each station will have two fueling positions and each will be capable of supplying up to 900 kilograms of hydrogen per day.

This expansion is Iwatani’s largest to date single investment in California and will bring the company’s total global hydrogen refueling station network to 64.

Joseph S. Cappello, CEO of Iwatani Corporation of America, commented, “Iwatani is truly privileged to collaborate with Toyota and Nel Hydrogen, two leaders in the Hydrogen Society, to bring world-class, hydrogen re-fueling technology to the California mobility market. The seven new stations in California are the latest demonstration of Iwatani’s commitment to investing in California’s light and heavy-duty hydrogen infrastructure and to create new jobs in the state.”

“Expanding the refueling station infrastructure in California is evidence of the growing demand for zero emission vehicles, we look forward to supporting Iwatani America in this next phase,” said Doug Murtha, Toyota Motor North America’s group vice president of corporate strategy and planning. “Our second generation and all-new 2021 Toyota Mirai will be arriving at dealers later this year, so it’s the perfect time to grow the hydrogen fueling network.”

Ulrik Torp Svendsen, Key Account Manager, Nel Hydrogen commented, “From Nel we are very honored that Iwatani and Toyota have selected our H2Station™ hydrogen fueling station solutions for strengthening the hydrogen infrastructure in Southern California. The stations will serve existing as well as new fuel cell electric vehicles, such as the next generation Toyota Mirai, with zero-emission fuel, at the same convenience as conventional fuels. With our Nel Inc. entity currently based in the San Francisco area we now look forward to expanding our business in California and supporting Iwatani.” 

About Iwatani Corporation’s Commitment to Hydrogen

Since 1941, Iwatani has regarded hydrogen as the ultimate clean energy source and has consistently engaged in initiatives to encourage its widespread use. Under the corporate slogan “A world where all enjoy true comfort – this is Iwatani’s desire,” Iwatani strives to solve environmental concerns with the aim of achieving a carbon- free society through the use of hydrogen.

Iwatani is Japan’s only fully integrated supplier of hydrogen and presently supplies its base of light and heavy-duty hydrogen refueling stations and industrial customers via five liquid and ten gaseous hydrogen production plants throughout the country. In addition, Iwatani is a steering member of the Hydrogen Council, a global initiative of leading energy, transport and industry companies, with a united vision and long-term ambitions for hydrogen to foster the energy transition. Iwatani is developing hydrogen refueling stations with the aim of stimulating new hydrogen demand and supporting the widespread distribution of FCEVs.

Relevant initiatives are being promoted in cooperation with Japan H2 Mobility, which was jointly established by infrastructure operators, automakers, financial investors and other stakeholders as the driving force for developing hydrogen refueling stations. Iwatani participates in initiatives involving carbon-free hydrogen, including a demonstration project for the production, transportation and storage of large quantities of liquid hydrogen in Australia, and the Fukushima Plan for a New Energy Societyone of the world’s largest hydrogen production projects, using renewable energy with zero CO2 emissions. In addition, Iwatani is an executive member of the California Fuel Cell Partnership and a member of the California Hydrogen Business Council and the Hydrogen Safety Council of the American Institute of Chemical Engineers.

Iwatani Corporation of America has headquarter offices in Houston, Texas and Santa Clara, California.

About Toyota

Toyota (NYSE:TM) has been a part of the cultural fabric in the U.S. and North America for more than 60 years, and is committed to advancing sustainable, next-generation mobility through our Toyota and Lexus brands. During that time, Toyota has created a tremendous value chain as our teams have contributed to world-class design, engineering, and assembly of more than 40 million cars and trucks in North America, where we have 14 manufacturing plants, 15 including our joint venture in Alabama (10 in the U.S.), and directly employ more than 47,000 people (over 36,000 in the U.S.). Our 1,800 North American dealerships (nearly 1,500 in the U.S.) sold nearly 2.8 million cars and trucks (nearly 2.4 million in the U.S.) in 2019.

About Nel Hydrogen

Nel ASA (OSE:NEL)  is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today.

Media Contact:

Tania Saldana

[email protected]

859-815-9968

Rebecca Pancheri

[email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/iwatani-corporation-of-america-and-toyota-collaborate-to-bring-seven-new-hydrogen-refueling-stations-to-southern-california-301171559.html

SOURCE Toyota Motor North America

Kiadis announces new data related to its K-NK cell therapy platform presented today at the SITC Annual Meeting

Data presented support the potential of combining oncolytic virotherapy along with PM21-NK cell adoptive therapy against lung cancer

Amsterdam, The Netherlands, November 12, 2020 – Kiadis Pharma N.V. (“Kiadis” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative cell-based medicines for the treatment of life-threatening diseases, today announces that new data related to its K-NK cell therapy platform will be presented at the 2020 Society for Immunotherapy of Cancer (SITC) virtual Annual Meeting being held November 9-14, 2020. Poster #454, from the labs of Alicja Copik, Ph.D., and Dr. Griff Parks at the University of Central Florida, will present data that support the potential of combining oncolytic virotherapy along with PM21-NK cell adoptive therapy against lung cancer.

Poster #454:
Oncolytic Parainfluenza Virus 5 Vector Enhances Natural Killer Cell Killing of Lung Tumor Cells in 2D and 3D spheroid cultures

Oncolytic viruses are viral vectors that preferentially target cancer cells, leaving healthy cells intact. Natural killer (NK) cells are innate immune cells with natural cytotoxicity towards both tumor cells and virus infected cells. This study explored the combination of the two investigational therapies, oncolytic virotherapy and adoptive PM21-NK cell therapy, enhancing the overall killing of lung cancer cells in both 2-dimensional (2D) and 3-dimensional (3D) tumor cultures.

Results in the 2D cultures show that PM21-NK cells more efficiently kill A549 cells that have been infected with P/V CPI- virus and enhance the overall rate of killing compared to uninfected cell targets. In 3D cultures of A549 tumor spheroids, although PIV5-P/V infection was limited to the outer layer of the spheroid, the addition of PM21-NK cells to PIV5-P/V-infected spheroids resulted in killing of not only the infected surface of the spheroid, but continued to the uninfected cells located at the center of the spheroid.

All SITC posters are on display from 8 a.m. on November 9 until the virtual poster hall closes on December 31, 2020.

Dutch Translation/Nederlandse vertaling


Kiadis Pharma

N.V. (‘Kiadis’) is een Nederlands beursgenoteerd biotechbedrijf in de klinische fase dat nieuwe geneesmiddelen ontwikkelt tegen ernstige ziekten. Het maakt daarbij gebruik van Natural Killer-cellen (NK-cellen), grote witte bloedlichamen die de eerste verdedigingslinie in het menselijk afweersysteem vormen tegen kankercellen en infecties. Kiadis maakt bekend dat nieuwe data met betrekking tot haar K-NK-celtherapieplatform zullen worden gepresenteerd op de virtuele jaarvergadering 2020 van de Society for Immunotherapy of Cancer (SITC) van 9-14 november 2020.

Poster #454 van het laboratorium van Alicja Copik, Ph.D. en Dr. Griff Parks van de University of Central Florida, omvat data die het potentieel ondersteunen van de combinatie van oncolytische virotherapie met PM21-NK celadoptie tegen longkanker.

Poster #454: De Oncolytische Para-influenza Virus 5 Vector verbetert het vermogen van Natural Killer-cellen tot het doden van longtumorcellen in 2D- en 3D-sferoïde culturen

Oncolytische virussen zijn virale vectoren die zich bij voorkeur richten op kankercellen, waardoor gezonde cellen intact blijven. Natural Killer (NK)-cellen zijn aangeboren immuuncellen met natuurlijke cytotoxiciteit voor zowel tumorcellen als met virus geïnfecteerde cellen. Deze studie onderzocht de combinatie van de twee onderzoekstherapieën, oncolytische virotherapie en adoptieve PM21-NK-celtherapie, waarmee de algehele doding van longkankercellen in zowel 2-dimensionale (2D) als 3-dimensionale (3D) tumorkweken werd verbeterd.

Resultaten in de 2D-culturen laten zien dat PM21-NK-cellen op efficiëntere wijze A549-cellen doden die zijn geïnfecteerd met P/V CPI-virus en de algehele snelheid van doden verhogen in vergelijking met niet-geïnfecteerde celdoelen. In 3D-culturen van A549-tumor-sferoïden, hoewel daarbij PIV5-P/V-infectie beperkt was tot de buitenste laag van de sferoïde, resulteerde de toevoeging van PM21-NK-cellen aan PIV5-P/V-geïnfecteerde sferoïden in het doden van niet alleen het geïnfecteerde oppervlak van de sferoïde, maar zette zich voort naar de niet-geïnfecteerde cellen in het midden van de sferoïde.

SITC posters zijn te zien vanaf 9 november om 8 uur ‘s ochtends tot de sluiting van de virtuele posterzaal op 31 december 2020.

Dit persbericht vormt een samenvatting van het gepubliceerde Engelstalige persbericht. Bij eventuele verschillen is de tekst van het Engelstalige persbericht altijd leidend.

Contacts

Kiadis:

Maryann Cimino, Sr. Manager, Corporate Affairs
Tel: +1 (617) 710-7305
[email protected]

 

LifeSpring Life Sciences Communication:

Leon Melens (Amsterdam)
Tel: +31 538 16 427
[email protected]

Optimum Strategic Communications:
Mary Clark, Supriya Mathur
Tel: +44 203 950 9144
[email protected]

About Kiadis

Founded in 1997, Kiadis is building a fully integrated biopharmaceutical company committed to developing innovative cell-based medicines for patients with life-threatening diseases. With headquarters in Amsterdam, The Netherlands, and offices and activities across the United States, Kiadis is reimagining medicine by leveraging the natural strengths of humanity and our collective immune system to source the best cells for life.

Kiadis is listed on the regulated market of Euronext Amsterdam and Euronext Brussels since July 2, 2015, under the symbol KDS. Learn more at www.kiadis.com.

Forward Looking Statements

Certain statements, beliefs and opinions in this press release are forward-looking, which reflect Kiadis’ or, as appropriate, Kiadis’ officers’ current expectations and projections about future events. By their nature, forward-looking statements involve a number of known and unknown risks, uncertainties and assumptions that could cause actual results, performance, achievements or events to differ materially from those expressed, anticipated or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, regulation, competition and technology, can cause actual events, performance, achievements or results to differ significantly from any anticipated or implied development. Forward-looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, Kiadis expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or projections, or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based. Neither Kiadis nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the anticipated or implied developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

SBM Offshore Third Quarter Trading Update

November 12, 2020


Highlights

  • 2020 Directional1 EBITDA guidance increased from above US$900 million to around US$950 million despite challenging environment
  • 2020 Directional revenue guidance maintained at around US$2.3 billion
  • Renewable energy: Floating Offshore Wind Provence Grand Large project moving ahead
  • Year-to-date Underlying Directional revenue of US$1,706 million
  • Second Fast4Ward® hull for Prosperity project completed

Bruno Chabas, CEO of SBM Offshore, commented:

“SBM Offshore is demonstrating the strength of its business model with another good set of results last quarter, despite the twin challenges of the global pandemic and low oil prices. Based on this solid year-to-date performance and the Company’s discipline in managing its cost base, the Company increased its full-year guidance.

SBM Offshore teams are succeeding in maintaining our focus on project delivery and safe operations, while working together virtually, across time zones, with clients, suppliers and all our other global stakeholders with the aim of limiting delivery delays and interruptions to operations. Deepwater projects in quality basins continue to rank favorably in client portfolios.

The energy transition remains at the core of the Company’s strategy. This quarter saw an important milestone reached with the start of the EPC phase of our first floating offshore wind project in France. Leveraging the learnings from this pilot project will enable SBM Offshore to further fine-tune its technology and execution model and to scale up for future projects towards our ambition to have 25% of revenues from Renewables & Gas by 2030.”

Financial Highlights

    YTD Directional
         
in US$ million   3Q 2020 3Q 2019 % Change
Revenue   1,806 1,470 23%
Lease and Operate   1,334 972 37%
Turnkey   472 498 -5%
Underlying Revenue   1,706 1,470 16%
Lease and Operate   1,234 972 27%
Turnkey   472 498 -5%
         
in US$ million   3Q 2020 3Q 2019  
Non-recurring items impact Revenue        
Deep Panuke redelivery   100  
         
in US$ billion   Sep-30-20 Dec-31-19 % Change
Net Debt   4.0 3.5 14%
Backlog calculation will be provided in FY20 Earnings Update        

Year to date, Underlying Directional revenues were US$1,706 million compared with US$1,470 million in the third quarter of 2019. This 16% increase resulted from higher revenues in Lease and Operate, which were the result of FPSO Liza Destiny joining the fleet at the end of 2019, together with last year’s acquisition of a minority partner’s ownership in five Brazilian FPSOs.

Underlying Directional revenues are adjusted for the non-recurring revenue recognition of US$100 million related to the redelivery of the Deep Panuke platform as reported with Half Year 2020 earnings. This redelivery does not affect the contractually agreed amount and timing of the cash consideration to be received by the Company as per the initial contract.

Compared with year-end 2019, net debt as at the end of the third quarter increased by c. US$0.5 billion to US$4.0 billion. While Lease and Operate continues to generate strong operating cash flow, the Company is drawing under the project loan facilities for continued investment in growth. As at September 2020, 76% of the debt consisted of non-recourse project financing, with remaining debt linked to the financing of the projects under construction. SBM Offshore is currently progressing with three major projects (FPSOs LizaUnity, Prosperity and Sepetiba) using the first three Multi-Purpose Floater (MPF) hulls in the Fast4Ward® program. The fourth hull in the program is under construction, with construction of the fifth not yet started.

Following the re-appointment of CEO Bruno Chabas at the 2020 AGM, the implementation of his Base Salary increase to EUR960,000 was deferred to a later stage when the effects of the COVID-19 crisis would be clearer. With more visibility at present and considering the financial results and the position of the Company, the Supervisory Board resolved to implement the increase of Bruno Chabas’ Base Salary effective January 1, 2020.


Project Review

SBM Offshore construction activities are reliant upon global supply chains, which face challenges to varying degrees from the pandemic. Project teams continue to work closely with client teams and contractors to optimize cost or schedule impacts and create alternatives for execution planning. An update on individual projects is provided below.

FPSO Liza Destiny

Commissioning work on the natural gas injection system of FPSO Liza Destiny is progressing with the main gas compressors commissioned.

FPSO Liza Unity

The yards in Singapore re-opened during the last quarter and the construction of the FPSO is progressing. The mooring and riser structures integration was completed and the Fast4Ward® MPF hull was moved from the dry-dock to the integration quayside where the topsides integration phase has started with the lifting of the first topsides modules. The project is progressing in line with client schedule, with a planned completion in 2022.

FPSO Sepetiba

The Fast4Ward® MPF hull construction is progressing at the yard in China, which is operating at planned capacity since mid-year 2020. The modules fabrication continues to progress in Brazil and China. The project is progressing with a planned completion end 2022.

FPSO Prosperity

Following the contracts award announced on October 1, 2020, the Prosperity project team is preparing for the start of fabrication in Singapore. The Fast4Ward® MPF hull for the project has been completed. The project is progressing in line with client schedule with a planned completion in 2024.

Fast4Ward® MPF hulls

Under the Company’s Fast4Ward® program the total number of hulls ordered to date stands at five. Three hulls are allocated to projects: FPSOs LizaUnity, Prosperity and Sepetiba. The two hulls allocated to FPSO LizaUnity and FPSO Prosperity are completed.

Regarding the hulls not allocated to projects, hulls number four and five, construction of the fourth hull is making progress in line with SBM Offshore’s execution plan and construction of the fifth hull is expected to start during the fourth quarter of this year. These hulls support ongoing tendering activity. 


Operational Update

Due to the ongoing COVID-19 pandemic, business continuity protocols remain in place. The Company is expanding its internal Polymerase Chain Reaction (PCR) testing capability and capacity, now available in most operating locations. This enables the Company to reduce quarantine periods and to provide a more efficient response if cases are identified. The priority remains to prevent the occurrence of cases on board of the Company’s fleet and in onshore locations and to minimize impact on operations.

Year to date, the Lease and Operate fleet uptime stood at 98.8% compared to 99.5% at mid-year 2020.


Energy Transition and HSSE

Floating Offshore Wind

SBM Offshore is contracted by EDF Renouvelables for the engineering, procurement, construction and installation of three floating units and its mooring system, for offshore wind turbines with a total capacity of 25.2 MW. The units will be deployed offshore Marseille for the project Provence Grand Large. The Company has progressed on the design and the turnkey phase is ongoing.

Total Recordable Injury Frequency Rate (TRIFR)

As at September 30, 2020, the Company’s year-to-date TRIFR was 0.12, compared with the 2020 target of 0.20. 


Outlook and Guidance

Supported by robust operational performance in both Lease and Operate and Turnkey and effective cost discipline measures, 2020 Directional EBITDA guidance is increased from “above” US$900 million to “around” US$950 million. 2020 Directional revenue guidance is maintained at “around” US$2.3 billion of revenues, with “around” US$1.6 billion coming from Lease and Operate and “around” US$0.7 billion coming from the Turnkey segment.

Consistent with the Half Year 2020 earnings update, this guidance excludes the exceptional positive impacts on revenue and EBITDA resulting from the redelivery of the Deep Panuke platform but includes negative impact on EBITDA resulting from the company restructuring costs.

The Directional EBITDA and revenue guidance take into account the currently foreseen COVID-19 impacts on projects and fleet operations. The Company highlights that the direct and indirect impact of the pandemic could have a material impact on the Company’s business and results. 


Conference Call

SBM Offshore has scheduled a conference call, which will be followed by a Q&A session, to discuss the Third Quarter 2020 Trading Update.

The event is scheduled for Thursday, November 12, 2020 at 10:00 am (CET) and will be hosted by Bruno Chabas (CEO), Douglas Wood (CFO), Philippe Barril (COO) and Erik Lagendijk (CGCO). 

Interested parties are invited to register prior to the call using the registration link:


https://www.kpneventcall.nl/EventRegistration/09b140d1-b9bb-448b-9bee-b24d923bfbdb

Please note that the conference call can only be accessed with a personal identification code, which is sent to you by email after completion of the registration. 

Corporate
Profile

The Company’s main activities are the design, supply, installation, operation and the life extension of floating production solutions for the offshore energy industry over the full lifecycle. The Company is market leading in leased floating production systems, with multiple units currently in operation.

As of December 31, 2019, the Company employs approximately 4,450 people worldwide spread over offices in our key markets, operational shore bases and the offshore fleet of vessels.

SBM Offshore N.V. is a listed holding company headquartered in Amsterdam, the Netherlands. It holds direct and indirect interests in other companies.

Where references are made to SBM Offshore N.V. and /or its subsidiaries in general, or where no useful purpose is served by identifying the particular company or companies “SBM Offshore” or “the Company” are sometimes used for convenience.

For further information, please visit our website at www.sbmoffshore.com.

The Management Board
Amsterdam, the Netherlands, November 12, 2020

Financial Calendar Date Year
Full Year 2020 Earnings – Press Release February 11 2021
Annual General Meeting of Shareholders April 7 2021
Trading Update 1Q 2021 – Press Release May 12 2021
Half Year 2021 Earnings – Press Release August 5 2021
Trading Update 3Q 2021 – Press Release November 11 2021


 

For further information, please contact:

Investor Relations

Bert-Jaap Dijkstra
Group Treasurer and IR

Telephone: +31 (0) 20 236 3222
Mobile: +31 (0) 6 21 14 10 17
E-mail: [email protected]
Website: www.sbmoffshore.com

Media Relations

Vincent Kempkes
Group Communications Director

Telephone: +31 (0) 20 236 3170
Mobile: +31 (0) 6 25 68 71 67
E-mail: [email protected]
Website: www.sbmoffshore.com

Disclaimer

This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. This press release contains
regulated information within the meaning of the Dutch Financial Markets Supervision Act (Wet op het financieel toezicht). Some of the statements contained in this release that are not historical facts are statements of future expectations and other forward-looking statements based on management’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those in such statements. Such forward-looking statements are subject to various risks and uncertainties, which may cause actual results and performance of the Company’s business to differ materially and adversely from the forward-looking statements. Certain such forward-looking statements can be identified by the use of forward-looking terminology such as “believes”, “may”, “will”, “should”, “would be”, “expects” or “anticipates” or similar expressions, or the negative thereof, or other variations thereof, or comparable terminology, or by discussions of strategy, plans, or intentions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in this release as anticipated, believed, or expected. SBM Offshore NV does not intend, and does not assume any obligation, to update any industry information or forward-looking statements set forth in this release to reflect subsequent events or circumstances. Nothing in this press release shall be deemed an offer to sell, or a solicitation of an offer to buy, any securities.


 

1 Directional view, presented in the Financial Statements under Operating segments and Directional reporting, represents a pro-forma accounting policy, which assumes all lease contracts are classified as operating leases and all vessel investees are proportionally consolidated. This explanatory note relates to all Directional reporting in this document.

 

 

Attachment

Sequana Medical to present at Jefferies 2020 Virtual London Healthcare Conference

GHENT, Belgium, Nov. 12, 2020 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces that Ian Crosbie, Chief Executive Officer, will present at the Jefferies 2020 Virtual London Healthcare Conference taking place from 17 to 19 November 2020.        

Company presentation
with live webcast

  • Thursday, 19 November 2020 at 11:35 am CET
  • To register for the webcast, click here
  • The presentation and a replay of the webcast will be available on Sequana Medical’s Investors website shortly after the event

To request a one-on-one meeting with the Sequana Medical management team, contact us at [email protected].

For more information, please contact:

Sequana Medical

Lies Vanneste, Director Investor Relations
Tel: +32 (0) 498 05 35 79
Email: [email protected]

Consilium Strategic Communications

Amber Fennell, Ashley Tapp, Melissa Gardiner
Tel: +44 203 709 5000
Email: [email protected]  
LifeSci Advisors

Chris Maggos
Tel: +41 79 367 6254
Email: [email protected]   

About Sequana Medical

Sequana Medical is a commercial stage medical device company developing the alfapump platform for the management of fluid overload in liver disease, malignant ascites and heart failure where diuretics are no longer effective. Fluid overload is a fast growing complication of advanced liver disease driven by NASH (non-alcoholic steatohepatitis) related cirrhosis and a common complication in heart failure. The U.S. market for the alfapump resulting from NASH-related cirrhosis is forecast to exceed €3 billion annually within the next 10-20 years. The heart failure market for the alfapump DSR (Direct Sodium Removal) is estimated to be over €5 billion annually in the U.S. and EU5 by 2026. Both indications leverage Sequana Medical’s alfapump, a unique, fully implanted wireless device that automatically pumps fluid from the abdomen into the bladder, where it is naturally eliminated through urination.

In the U.S., the company’s key growth market, the alfapump has been granted breakthrough device designation by the FDA. The North American pivotal study (POSEIDON) in recurrent and refractory ascites due to liver cirrhosis is currently underway, and is intended to support a commercial marketing application of the alfapump in the U.S. and Canada. In Europe, the alfapump is CE-marked for the management of refractory ascites due to liver cirrhosis and malignant ascites and is included in key clinical practice guidelines. Over 800 alfapump systems have been implanted to date. Building on its proven alfapump platform, Sequana Medical is developing the alfapump DSR, a breakthrough, proprietary approach to fluid overload due to heart failure. Clinical proof-of-concept was achieved in a first-in-human single dose DSR study and further supported by strong interim safety and efficacy results from the ongoing repeated dose alfapump DSR study (RED DESERT) in heart failure patients.

Sequana Medical is headquartered in Ghent, Belgium. For further information, please visit www.sequanamedical.com.


Important Regulatory Disclaimers


The 

alfa

pump® system is not currently approved in the United States or Canada. In the United States and Canada, the 

alfa

pump® system is currently under clinical investigation (POSEIDON Study) and is being studied in adult patients with refractory or recurrent ascites due to cirrhosis. For more information regarding the POSEIDON clinical study see 

www.poseidonstudy.com

. The DSR therapy is still in development and it should be noted that any statements regarding safety and efficacy arise from ongoing pre-clinical and clinical investigations which have yet to be completed. The DSR therapy is not currently approved for clinical research in the United States or Canada. There is no link between the DSR therapy and ongoing investigations with the 

alfa

pump® system in Europe.


Forward-looking statements


This press release may contain predictions, estimates or other information that might be considered forward-looking statements. Such forward-looking statements are not guarantees of future performance. These forward-looking statements represent the current judgment of Sequana Medical on what the future holds, and are subject to risks and uncertainties that could cause actual results to differ materially. Sequana Medical expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release, except if specifically required to do so by law or regulation. You should not place undue reliance on forward-looking statements, which reflect the opinions of Sequana Medical only as of the date of this press release.

Innate Pharma to Participate in upcoming investor conferences

MARSEILLE, France, Nov. 12, 2020 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that members of its senior management team are scheduled to participate in the following upcoming virtual investor conferences.

  • Bryan Garnier & Co Virtual European Healthcare Conference

    Date: November 17, 2020
    Fireside Chat: November 17, 2020 at 10:00 a.m. CET

  • Jefferies Virtual London Healthcare Conference

    Date: November 18, 2020

  • SVB Leerink Oncology 1×1 Day

    Date: November 19, 2020

  • Oddo – Tech40 Digital Forum 5

    th

    Edition

    Date: November 24-25, 2020

  • Evercore ISI 3

    rd

    Annual HealthCONx

    Date: December 1-3, 2020
    Fireside Chat: December 2, 2020 at 8:50-9:10 a.m. ET

A replay of Innate’s presentation at the Bryan Garnier conference and a live webcast of Innate’s presentation at the Evercore ISI conference will be accessible through the News & Events page of the Investors section of the Company’s website at www.innate-pharma.com.

About Innate Pharma:

Innate Pharma S.A. is a commercial stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

Innate Pharma’s commercial-stage product, Lumoxiti, in-licensed from AstraZeneca in the US, EU and Switzerland, was approved by the FDA in September 2018. Lumoxiti is a first-in class specialty oncology product for hairy cell leukemia. Innate Pharma’s broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.

Innate has been a pioneer in the understanding of natural killer cell biology and has expanded its expertise in the tumor microenvironment and tumor-antigens, as well as antibody engineering. This innovative approach has resulted in a diversified proprietary portfolio and major alliances with leaders in the biopharmaceutical industry including Bristol-Myers Squibb, Novo Nordisk A/S, Sanofi, and a multi-products collaboration with AstraZeneca.

Based in Marseille, France, Innate Pharma is listed on Euronext Paris and Nasdaq in the US.
Learn more about Innate Pharma at www.innate-pharma.com

Information about Innate Pharma shares:

ISIN code

Ticker code

LEI
FR0010331421
Euronext: IPH Nasdaq: IPHA
9695002Y8420ZB8HJE29

Disclaimer on forward-looking information and risk factors:

This press release contains certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995.The use of certain words, including “believe,” “potential,” “expect” and “will” and similar expressions, is intended to identify forward-looking statements. Although the company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies, review and approvals by regulatory authorities of its product candidates, the Company’s commercialization efforts, the Company’s continued ability to raise capital to fund its development and the overall impact of the COVID-19 outbreak on the global healthcare system as well as the Company’s business, financial condition and results of operations. For an additional discussion of risks and uncertainties which could cause the company’s actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors (“Facteurs de Risque”) section of the Universal Registration Document filed with the French Financial Markets Authority (“AMF”), which is available on the AMF website http://www.amf-france.org or on Innate Pharma’s website, and public filings and reports filed with the U.S. Securities and Exchange Commission (“SEC”), including the Company’s Annual Report on Form 20-F for the year ended December 31, 2019, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public, by the Company.

This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country.

For additional information, please contact:


Investors



Innate Pharma

Tel.: +33 (0)4 30 30 30 30
[email protected]


Media



Innate Pharma

Tracy Rossin (Global/US)
Tel.: +1 240 801 0076
[email protected]

ATCG Press
Marie Puvieux (France)
Tel.: +33 (0)9 81 87 46 72
[email protected]

Wix Announces Appointment of Ferran Soriano to its Board of Directors

PR Newswire

NEW YORK, Nov. 12, 2020 /PRNewswire/ — Wix.com Ltd (Nasdaq: WIX), the global leader in website creation, announced today the appointment of Ferran Soriano to its board of directors.

“We enthusiastically welcome Ferran to our board of directors,” said Avishai Abrahami, Co-founder and CEO of Wix. “Ferran is a seasoned executive who possesses deep expertise in building businesses and brands across multiple international markets. His background in a variety of industries will also bring new perspectives to our board, which we welcome as we focus on driving growth across our increasingly broadening platform.”

Mr. Soriano currently serves as the CEO of City Football Group (CFG), a position he has held since September 2012. Under his leadership, CFG has become a global platform for entertainment and football, redefining club ownership.

City Football Group is the world’s leading private owner and operator of football clubs, with total or partial ownership of ten clubs in major cities across the world: Premier League Champions Manchester City in the UK, New York City FC in the US, Melbourne FC in Australia, Yokohama F. Marinos in Japan, Montevideo City Torque in Uruguay, Girona Futbol Club in Spain, Sichuan Jiuniu FC in China, Mumbai City FC in India, Lommel SK in Belgium and ESTAC in France. With 13 offices around the world, CFG also invests in other football related businesses and projects and serves as a global commercial platform for its partners, whilst fulfilling its vision of using football for social good on a local and global scale through its clubs’ charities, foundations and other CSR initiatives. 

Previously, Soriano was Vice Chairman and CEO of FC Barcelona from 2003 to 2008 where he is credited with playing a major role in the transformation of the club to success on and off the pitch.

Soriano also served as Chairman of Spanair from 2009 to 2012 and previously spent 10 years as a partner and co-founder of Cluster Consulting (a/k/a DiamondCluster, Nasdaq: DTPI), a strategy consulting firm. Earlier in his career, Soriano served in various management positions at consumer goods company Reckitt-Benckiser.

Soriano also authored a book published in more than 10 countries and languages titled “Goal: The Ball Doesn’t Go In By Chance: Management Ideas from the World of Football”, which reveals the behind the scenes world of international football management and Soriano’s views on the lessons that can be learned.

Mr. Soriano holds a Bachelor’s degree in management and a MBA from ESADE (Barcelona), Rensselaer Polytechnic Institute (New York) and Université Catholique de Louvain (Belgium).


About Wix.com Ltd.



Wix
 is leading the way with a cloud-based website development platform for over 189 million registered users worldwide today. The Wix website builder was founded on the belief that the Internet should be accessible to everyone to develop, create and contribute. Through free and premium subscriptions, Wix empowers millions of businesses, organizations, artists, and individuals to take their businesses, brands and workflow online. The Wix Editor, Wix ADI, Editor X, a highly curated App Market, Ascend by Wix and Corvid by Wix enable users to build and manage a fully integrated and dynamic digital presence. Wix’s headquarters are in Tel Aviv with offices in Austin, Be’er Sheva, Berlin, Cedar Rapids, Denver, Dnipro, Dublin, Kiev, Los Angeles, Miami, New York, San Francisco, São Paulo, Tokyo and Vilnius. 

Visit us: on our blog, Facebook, Twitter, Instagram, LinkedIn and Pinterest 
Download: Wix App is available for free on Google Play and in the App Store.

For more about Wix please visit our Press Room

Investor Relations:

Maggie O’Donnell


[email protected] 
914-267-7390

Media Relations:


[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/wix-announces-appointment-of-ferran-soriano-to-its-board-of-directors-301171496.html

SOURCE Wix.com Ltd.

Liberty Global Completes Acquisition of Sunrise Communications Group

Liberty Global Completes Acquisition of Sunrise Communications Group

Liberty Owns 98% of Sunrise Shares After Settlement of Tender Offer

Squeeze-Out Procedure will be Initiated and Sunrise Shares will be Delisted

DENVER, Colorado–(BUSINESS WIRE)–
Liberty Global (Nasdaq: LBTYA, LBTYB and LBTYK) has successfully completed the acquisition of Sunrise Communications AG (SIX Swiss Exchange: SRCG).

Following receipt of the regulatory approvals and fulfilment of further purchase conditions, the completion of the transaction has taken place today with the settlement of the all cash public tender offer of UPC Schweiz GmbH (a subsidiary of Liberty Global) to acquire all publicly held shares of Sunrise Communications Group AG (“Sunrise”).

Liberty Global (through UPC Schweiz GmbH) now holds more than 98% of the share capital of Sunrise and will initiate a squeeze-out according to the Swiss Financial Market Infrastructure Act. Liberty Global plans to have the Sunrise shares delisted from the SIX Swiss Exchange upon completion of the squeeze-out. Sunrise is therefore expected to become a wholly-owned subsidiary within the Liberty Global group.

While both Sunrise and UPC Schweiz GmbH will both be subsidiaries of Liberty Global, they will continue to operate independently until the integration of the two companies is completed in early 2021.

Mike Fries, CEO, Liberty Global, comments, “Today marks another important step in our strategy of creating leading national fixed-mobile champions across Europe. By bringing together UPC’s leading gigabit broadband network and the most advanced 5G network of Sunrise, the combined company will provide seamless connectivity for millions of Swiss consumers and thousands of Swiss businesses.”

ABOUT LIBERTY GLOBAL

Liberty Global (NASDAQ: LBTYA, LBTYB and LBTYK) is one of the world’s leading converged video, broadband and communications companies, with operations in 6 European countries under the consumer brands Virgin Media, Telenet and UPC. We invest in the infrastructure and digital platforms that empower our customers to make the most of the digital revolution.

Our substantial scale and commitment to innovation enable us to develop market-leading products delivered through next-generation networks that connect 11 million customers subscribing to 25 million TV, broadband internet and telephony services. We also serve 6 million mobile subscribers and offer WiFi service through millions of access points across our footprint.

In addition, Liberty Global owns 50% of VodafoneZiggo, a joint venture in the Netherlands with 4 million customers subscribing to 10 million fixed-line and 5 million mobile services, as well as significant investments in ITV, All3Media, ITI Neovision, LionsGate, the Formula E racing series and several regional sports networks.

For more information, please visit www.libertyglobal.com.

IMPORTANT ADDITIONAL INFORMATION

This release is for informational purposes only and does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer, to purchase or subscribe for any registered shares in Sunrise or Sunrise’s ADSs, nor shall it form the basis of, or be relied on in connection with, any contract therefor. Shareholders of Sunrise are urged to read the documents relating to the tender offer described herein (the Offer), which are available at www.nationalconnectivitychallenger.ch. The Offer has closed, but Liberty Global reserves the right to purchase additional Sunrise shares prior to the squeeze-out in accordance with all applicable laws.

U.S. shareholders of Sunrise may also call +1 303 220 6600 (US) or email [email protected] to request a copy of the Offer documents, which will be provided free of charge upon request. Sunrise is incorporated in Switzerland and listed on the SIX Swiss Exchange, and any offer for its securities will be subject to Swiss disclosure and procedural requirements, which differ from those that are applicable to offers conducted solely in the United States. The transactions described above were structured to comply with securities laws and regulations applicable to transactions of this type. The communication is not being made by, and has not been approved by, an “authorised person” for the purposes of Section 21 of the U.K. Financial Services and Markets Act 2000.

FORWARD-LOOKING STATEMENTS

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “may,” “target,” and similar expressions and variations or negatives of these words. These forward-looking statements may include, among other things, statements relating to the outlook in Switzerland of Sunrise and Liberty Global; operational expectations, including with respect to the development, launch and benefits of innovative and advanced products and services, including gigabit speeds, new technology and next generation platform rollouts or launches; future growth prospects and opportunities, results of operations, uses of cash, tax rates, and other measures that may impact the financial performance of the companies; anticipated benefits and synergies and estimated costs of the transaction; the expected timing of completion of the transaction; and other information and statements that are not historical facts. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. These risks and uncertainties include events that are outside of the control of the parties, such as: (i) Sunrise, Liberty Global, and our respective operating companies’ ability to meet challenges from competition and to achieve forecasted financial and operating targets; (ii) the effects of changes in laws or regulations; (iii) general economic, legislative, political and regulatory factors, and the impact of weather conditions, natural disasters, or any epidemic, pandemic or disease outbreak (including COVID-19); (iv) Liberty Global and our affiliates’ ability to successfully integrate Sunrise and realize anticipated efficiencies and synergies from the transaction; (v) the outcome of any potential litigation that may be instituted with respect to the transaction; (vi) the potential impact of unforeseen liabilities, future capital expenditures, revenues, expenses, economic performance, indebtedness, financial condition on the future prospects and business of Sunrise and Liberty Global’s Swiss business after the consummation of the transaction; and (vii) management’s response to any of the aforementioned factors. For additional information on identifying factors that may cause actual results to vary materially from those stated in forward-looking statements, please see Liberty Global’s filings with the U.S. Securities and Exchange Commission, including Liberty Global’s most recently filed Form 10-Q. These forward-looking statements speak only as of the date of this release. Sunrise and Liberty Global expressly disclaim any obligation or undertaking to disseminate any updates or revisions to any forward-looking statement contained herein to reflect any change in expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Investor Relations:

Max Adkins +44 20 8483 6336

John Rea +1 303 220 4238

Stefan Halters +44 20 8483 6211

Corporate Communications:

Molly Bruce +1 303 220 4202

Matt Beake +44 20 8483 6428

KEYWORDS: United States North America Colorado

INDUSTRY KEYWORDS: Technology Telecommunications

MEDIA:

Global Warming Solutions Inc. Introduces an Energy Solution in the Fight Against Global Warming

Jacksonville, Florida, Nov. 12, 2020 (GLOBE NEWSWIRE) — Global Warming Solutions, Inc. is driving our generation’s challenge to reduce greenhouse gas emissions. The world is rapidly demanding more clean and renewable energy, but accelerating the adoption of renewables presents many challenges, including reliability, resiliency, scalability, and land use. Hydrogen energy is by far the most promising way of solving environmental problems. It remains the only promising way to solve the main issue – long-term storage and safe transportation of hydrogen.

At some point in time, we will have more renewable energy than the grid can handle in some states in the US. Despite these periods of surplus wind and solar energy, seeing as how  we are unable to store electricity for more than a few hours, dispatching energy from fossil fuels continues to fill energy supply gaps.

We also are currently experiencing more power outages than ever before, especially during peak grid loads. Wildfires, tornadoes, hurricanes, and winter storms cause hundreds of blackouts each year, with more blackouts lasting days (rather than minutes or hours). Now more than ever, we need renewable, reliable, and resilient energy.

Global Warming Solutions Inc. is working on introducing to the world, a power generation device that effectively delivers constant 100% renewable, emission-free electricity 24 hours a day, 365 days per year.

“Production/storage and shipping of hydrogen from excess renewable energy sources is associated with a number of unresolved technical problems. We offer today a scalable, affordable, and effective solution to the problem of balancing supply and demand for renewable energy sources. ”said Artym Madatov of Global Warming Solutions, Inc. “Consumer availability of 100% renewable and clean energy, can only be real with stand-alone, scalable solutions to safely store this type of renewable energy.”

“Scaling up clean and renewable energy means that consumers of all sizes can now purchase an autonomous energy storage device with the capacity they need. This does not require waiting for the implementation of super-large-scale projects, such as the construction of networks with hydrogen pipelines and giant hydrogen storage facilities. Everyone can create their own sustainable energy network. ”said Vladimir Vasilenko, CEO of Global Warming Solutions, Inc. “Today’s fuel cells, wind and solar power, reduce CO2 emissions by ways that are largely independent of one another . In the future, these same technologies will work in sync to balance supply and demand. ”

How does it work?

An exclusive feature of the “Sustainable Energy Device ” on hydrogen is the transportation of energy to the place of energy storage, not hydrogen, which is both dangerous, and expensive.   However, the transmission of electricity through wires is inexpensive and safe. Energy from renewable sources is supplied to a Sustainable Energy Device, then stored (without loss) in the form of sodium inside an electrochemical reactor. The automatic start-up of an electrochemical reactor produces hydrogen, which is oxidized in fuel cells to produce clean energy which is then fed into the grid. During peak periods of consumption, energy from renewable sources are used to recover sodium. Thus, wind and solar energy are stored and consumed when the consumer requires it.

The ability to work on extempore obtained renewable hydrogen means that Sustainable Energy Devices can be installed today where it is convenient for the electrical grid, and the consumer. This determines the scalability of the project:  every energy consumer who wants to ensure the sustainability of the energy supply for himself can now establish a “Point of Sustainable Energy.”

“Following some of the biggest names concerned with global warming such as the Gate’s Foundation, we feel very comfortable with the direction we are headed”, concluded Dr. Vasilenko.

To learn more about Global Warming Solutions, Inc. Visit: http://www.gwsogroup.com

Forward-Looking Statements

This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at https://www.gwsogroup.com.

Contact:

Vladimir Vasilenko
CEO
Global Warming Solutions, Inc.
[email protected]

McAfee and Amazon Business Prime Partner to Protect Small Business Owners Online

McAfee and Amazon Business Prime Partner to Protect Small Business Owners Online

McAfee’s comprehensive device protection offer with added IT support solves small business challenges

NEWS HIGHLIGHTS

  • McAfee and Amazon Business Prime partner to solve cyber security and IT resource challenges
  • Exclusive offers now available for Business Prime Members in the U.S.

SAN JOSE, Calif.–(BUSINESS WIRE)–
McAfee Corp. (Nasdaq: MCFE) today announced a partnership with Amazon Business to provide an exclusive security software and IT services bundle for Business Prime members, specifically to support owners of small to medium size operations (SMBs). The bundle will include comprehensive solutions that protect sensitive data via email, offer web and firewall protection, offer mobile VPN, and safeguards all devices from malware and the latest online threats.

In an increasingly digitized world, small businesses are targeted by hackers because they often lack the resources to prepare and address cyber threats, both from a budgetary and staffing perspective. The 2019 Verizon Data Breach Investigations Report found that 43% of breaches involved small businesses, and it has proven to be challenging for small business to recover. It isn’t always the impact on finances that are hard for small businesses to recover from – it is also their reputation that is damaged, and their customers take note when their personal information is compromised.

“Small business owners and consumers alike are operating in an ever-connected world, and McAfee is dedicated to protecting them online when they shop, bank, share and journey across the internet,” said Terry Hicks, Executive Vice President of McAfee’s Consumer Business Group. “Through our partnership with Amazon Business, we designed a security solution with small business owners in mind to give them peace of mind that their personal data, as well as their customers’, won’t be jeopardized online.”

The new McAfee security software and IT services bundle for Business Prime members will provide protection for varying number of PCs, Macs, iOS and Android devices to fit specific business size and needs. The flexible licensing option allows owners to add up to 25 devices, giving them the option to adjust as their business grows to ensure that all employees stay protected. SMB owners will also have access to 24/7 virus removal service with added IT resolution services to ensure businesses are always protected, secure and functioning efficiently.

For the first year of the offering, Business Prime members can choose between three introductory price options, ranging from $49.99 to $99.99, depending on the number of devices and IT resolutions that members deem appropriate for their business needs. Prices range from $149.99 to $249.99 per year thereafter upon annual renewal. To redeem the offer, a member can log-in to their Amazon Business Prime account, click into the offer on the Engagement Page, select the option appropriate for their business size, redeem online with McAfee, and immediately download the McAfee client onto their respective business device. Members can then access their McAfee MyAccount admin portal to easily add incremental devices or start inviting team members to access the credits.

Amazon Business helps millions of customers worldwide—from small businesses, schools, hospitals, and government agencies, to large enterprises with global operations—reshape their procurement with cost and time savings, greater productivity, and insightful purchasing analytics. Amazon Business customers can also take advantage of Prime’s fast, free shipping on eligible orders and exclusive business-relevant benefits with Business Prime, which starts at $69 per year as an add-on for customers with Amazon Prime on their personal account or $179 per year for up to three users.

Visit www.amazon.com/businessprime for more details.

About McAfee

McAfee Corp. (Nasdaq: MCFE) is a leader in personal security for consumers. Focused on protecting people, not just devices, McAfee consumer solutions adapt to users’ needs in an always online world, empowering them to live securely through integrated, intuitive solutions that protects their families and communities with the right security at the right moment. For more information, please visit https://www.mcafee.com/consumer

Ashley Dolezal

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Professional Services Security Technology Small Business Software Internet

MEDIA: